KEGG   DRUG: Canagliflozin and metformin
Entry
D10587            Mixture   Drug                                   
Name
Canagliflozin and metformin;
Invokamet (TN)
Product
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (Janssen Pharmaceuticals)
Component
(Metformin hydrochloride [DR:D00944] | Metformin [DR:D04966]), Canagliflozin hydrate [DR:D09592]
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG03034  Combination of metformin and SGLT2 inhibitor
Remark
ATC code: A10BD16
Product: D10587<US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD16 Metformin and canagliflozin
      D10587  Canagliflozin and metformin <US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Canagliflozin/ Metformin Hydrochloride
    D10587  Canagliflozin and metformin
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG03034  Combination of metformin and SGLT2 inhibitor
    D10587  Canagliflozin and metformin
Drug classes [BR:br08332]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D10587  Canagliflozin and metformin
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10587
Other DBs
PubChem: 254741549
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system